272 related articles for article (PubMed ID: 37766117)
1. Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy.
Guo Y; Ma R; Zhang M; Cao Y; Zhang Z; Yang W
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766117
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
Front Oncol; 2019; 9():1196. PubMed ID: 31781498
[TBL] [Abstract][Full Text] [Related]
3. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
Yu S; Xiao H; Ma L; Zhang J; Zhang J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
[TBL] [Abstract][Full Text] [Related]
4. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
5. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
6. Decoding immunogenic cell death from a dendritic cell perspective.
Janssens S; Rennen S; Agostinis P
Immunol Rev; 2024 Jan; 321(1):350-370. PubMed ID: 38093416
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Immunogenic Cell Death and Antigen Presentation
He T; Wang L; Gou S; Lu L; Liu G; Wang K; Yang Y; Duan Q; Geng W; Zhao P; Luo Z; Cai K
ACS Nano; 2023 Jun; 17(11):9953-9971. PubMed ID: 37212750
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death.
Liu Q; Sun Y; Yin X; Li J; Xie J; Xie M; Wang K; Wu S; Li Y; Hussain M; Jiang B; Liu Y; Huang C; Tao J; Zhu J
ACS Appl Bio Mater; 2020 May; 3(5):3378-3389. PubMed ID: 35025380
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.
Guo ZS; Liu Z; Bartlett DL
Front Oncol; 2014; 4():74. PubMed ID: 24782985
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment-triggered
Ding B; Zheng P; Li D; Wang M; Jiang F; Wang Z; Ma P; Lin J
Nanoscale; 2021 Jun; 13(24):10906-10915. PubMed ID: 34128036
[TBL] [Abstract][Full Text] [Related]
11. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
Chen Q; Li C; Wang Q
Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
[TBL] [Abstract][Full Text] [Related]
13. Promotion of ICD via Nanotechnology.
Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.
Li Z; Lai X; Fu S; Ren L; Cai H; Zhang H; Gu Z; Ma X; Luo K
Adv Sci (Weinh); 2022 Aug; 9(22):e2201734. PubMed ID: 35652198
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy.
Palanivelu L; Liu CH; Lin LT
Front Immunol; 2022; 13():1038226. PubMed ID: 36755812
[TBL] [Abstract][Full Text] [Related]
16. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.
Ogawa M; Tomita Y; Nakamura Y; Lee MJ; Lee S; Tomita S; Nagaya T; Sato K; Yamauchi T; Iwai H; Kumar A; Haystead T; Shroff H; Choyke PL; Trepel JB; Kobayashi H
Oncotarget; 2017 Feb; 8(6):10425-10436. PubMed ID: 28060726
[TBL] [Abstract][Full Text] [Related]
19. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
20. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
